Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys436
Sells8305
Buy $$173.20M
Sell $$11.46B
Ratio1:66.19
% Change vs. Prior
Ratio -97.3%Value -49.5%
Healthcare
Buys622
Sells4388
Buy $$391.59M
Sell $$6.41B
Ratio1:16.37
% Change vs. Prior
Ratio +61.8%Value -45.5%
Consumer Cyclical
Buys430
Sells1641
Buy $$1.03B
Sell $$5.08B
Ratio1:4.95
% Change vs. Prior
Ratio +850.9%Value +11.0%
Energy
Buys221
Sells519
Buy $$309.14M
Sell $$5.68B
Ratio1:18.37
% Change vs. Prior
Ratio +201.5%Value +27.7%
Financial Services
Buys1068
Sells2574
Buy $$635.97M
Sell $$3.55B
Ratio1:5.59
% Change vs. Prior
Ratio -7.4%Value -9.7%
Industrials
Buys518
Sells1908
Buy $$1.51B
Sell $$2.20B
Ratio1:1.46
% Change vs. Prior
Ratio +717.2%Value -19.7%
Consumer Defensive
Buys222
Sells539
Buy $$83.12M
Sell $$1.42B
Ratio1:17.05
% Change vs. Prior
Ratio -24.9%Value -30.5%
Communication Services
Buys170
Sells881
Buy $$155.76M
Sell $$1.00B
Ratio1:6.44
% Change vs. Prior
Ratio +22.3%Value -20.4%
Real Estate
Buys248
Sells203
Buy $$51.91M
Sell $$326.20M
Ratio1:6.28
% Change vs. Prior
Ratio +13.1%Value +38.9%
Basic Materials
Buys188
Sells217
Buy $$44.22M
Sell $$304.28M
Ratio1:6.88
% Change vs. Prior
Ratio +26.4%Value -20.6%
Utilities
Buys103
Sells171
Buy $$75.31M
Sell $$106.12M
Ratio1:1.41
% Change vs. Prior
Ratio +686.0%Value -79.9%
By Industry
Oil & Gas Exploration & Production
Buys111
Sells123
Buy $$158.25M
Sell $$4.22B
Ratio1:26.68
% Change vs. Prior
Ratio +112.2%Value +69.3%
Computer Hardware
Buys2
Sells1901
Buy $$9.90K
Sell $$2.61B
Ratio1:263658.02
% Change vs. Prior
Ratio -80.3%Value +15.9%
Software - Infrastructure
Buys79
Sells2473
Buy $$17.82M
Sell $$2.56B
Ratio1:143.65
% Change vs. Prior
Ratio -27.5%Value -26.3%
Software - Application
Buys163
Sells1968
Buy $$112.21M
Sell $$2.26B
Ratio1:20.17
% Change vs. Prior
Ratio -55.5%Value -23.8%
Biotechnology
Buys400
Sells2562
Buy $$340.74M
Sell $$1.84B
Ratio1:5.40
% Change vs. Prior
Ratio +67.7%Value -42.7%
Semiconductors
Buys106
Sells901
Buy $$11.50M
Sell $$2.05B
Ratio1:178.35
% Change vs. Prior
Ratio +387.7%Value -35.0%
Banks - Regional
Buys351
Sells991
Buy $$93.67M
Sell $$1.39B
Ratio1:14.85
Waste Management
Buys88
Sells13
Buy $$1.39B
Sell $$4.20M
Ratio330.83:1
Medical - Care Facilities
Buys4
Sells82
Buy $$346.12K
Sell $$1.32B
Ratio1:3800.99
Medical - Instruments & Supplies
Buys16
Sells139
Buy $$2.41M
Sell $$1.22B
Ratio1:505.41
% Change vs. Prior
Ratio -54.8%Value -67.0%
Information Technology Services
Buys40
Sells161
Buy $$21.31M
Sell $$1.18B
Ratio1:55.45
% Change vs. Prior
Ratio +191.3%Value -6.2%
Specialty Retail
Buys69
Sells780
Buy $$138.82M
Sell $$1.02B
Ratio1:7.35
% Change vs. Prior
Ratio +980.3%Value -40.4%
Asset Management
Buys345
Sells228
Buy $$415.83M
Sell $$714.50M
Ratio1:1.72
% Change vs. Prior
Ratio +338.6%Value +1.3%
Medical - Diagnostics & Research
Buys16
Sells686
Buy $$3.20M
Sell $$1.12B
Ratio1:349.93
% Change vs. Prior
Ratio -50.9%Value -9.8%
Apparel - Footwear & Accessories
Buys6
Sells37
Buy $$672.77K
Sell $$1.11B
Ratio1:1650.68
Transactions (26506)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
NETFLIX INC (NFLX)
Peters Gregory K — Director
Shares
27,312
Price
$73.54
Total Value
$2.01M
Shares Held After
120,931
% of Holdings
18.4%
Velocity Financial, Inc. (VEL)
Szczepaniak Mark R — Chief Financial Officer
Shares
400
Price
$18.00
Total Value
$7.20K
Shares Held After
66,400
% of Holdings
0.6%
Burke&Herbert Financial Services Corp. (BHRB)
McLaughlin Shawn Patrick — Director
Shares
1,000
Price
$73.25
Total Value
$73.25K
Shares Held After
71,000
% of Holdings
1.4%
Rhinebeck Bancorp, Inc. (RBKB)
Vitale Michael — EVP, Head of Comm Banking
Shares
4,834
Price
$12.35
Total Value
$59.70K
Shares Held After
22,414
% of Holdings
21.6%
WILSON BANK HOLDING CO (WBHC)
CLEMONS JAMES RANDALL — Director
Shares
2,982
Price
$83.45
Total Value
$248.85K
Shares Held After
116,090
% of Holdings
2.6%
FARMERS NATIONAL BANC CORP /OH/ (FMNB)
Wenick Mark J — SEVP/Chief Wealth Mgt Officer
Shares
5,000
Price
$15.97
Total Value
$79.85K
Shares Held After
32,020
% of Holdings
13.5%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
6,975
Price
$44.44
Total Value
$309.97K
Shares Held After
0
% of Holdings
100.0%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
25
Price
$46.56
Total Value
$1.16K
Shares Held After
6,975
% of Holdings
0.4%
Thornburg Income Builder Opportunities Trust (TBLD)
Kritzmire Anne W. — TRUSTEE
Shares
3,440
Price
$22.20
Total Value
$76.37K
Shares Held After
4,840
% of Holdings
71.1%
Infleqtion, Inc. (INFQ)
MAVERICK CAPITAL LTD — Director
Shares
1,324
Price
$10.88
Total Value
$14.41K
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
672
Price
$22.02
Total Value
$14.80K
Shares Held After
74,870
% of Holdings
0.9%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
753
Price
$21.97
Total Value
$16.54K
Shares Held After
75,542
% of Holdings
1.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$22.11
Total Value
$2.21K
Shares Held After
76,295
% of Holdings
0.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
480
Price
$21.55
Total Value
$10.34K
Shares Held After
76,395
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.10
Total Value
$4.42K
Shares Held After
76,875
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
3,402
Price
$22.02
Total Value
$74.91K
Shares Held After
77,075
% of Holdings
4.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,556
Price
$22.06
Total Value
$34.33K
Shares Held After
80,477
% of Holdings
1.9%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
82,033
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,332
Price
$22.03
Total Value
$29.34K
Shares Held After
82,233
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
447
Price
$21.87
Total Value
$9.78K
Shares Held After
83,565
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
988
Price
$22.03
Total Value
$21.77K
Shares Held After
84,012
% of Holdings
1.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
85,000
Price
$21.00
Total Value
$1.78M
Shares Held After
85,000
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
26506 transactions